The novel antiepileptic drug lacosamide blocks behavioral and brain metabolic manifestations of seizure activity in the 6 Hz psychomotor seizure model.
about
Development of lacosamide for the treatment of partial-onset seizuresLacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safetyLacosamide as a new treatment option in status epilepticusSpecific binding of lacosamide to collapsin response mediator protein 2 (CRMP2) and direct impairment of its canonical function: implications for the therapeutic potential of lacosamideInsights from zebrafish and mouse models on the activity and safety of ar-turmerone as a potential drug candidate for the treatment of epilepsyLacosamide: a new approach to target voltage-gated sodium currents in epileptic disordersLacosamide.Repeated 6-Hz Corneal Stimulation Progressively Increases FosB/ΔFosB Levels in the Lateral Amygdala and Induces Seizure Generalization to the HippocampusClinical perspectives on lacosamideProgressive Seizure Aggravation in the Repeated 6-Hz Corneal Stimulation Model Is Accompanied by Marked Increase in Hippocampal p-ERK1/2 Immunoreactivity in NeuronsPharmacotherapy of epilepsy: newly approved and developmental agents.Novel medications for epilepsy.Review of therapeutic options for adjuvant treatment of focal seizures in epilepsy: focus on lacosamide.Evaluating the Phase II drugs currently under investigation for diabetic neuropathy.Acute seizure tests in epilepsy research: electroshock- and chemical-induced convulsions in the mouse.Synergism of lacosamide with established antiepileptic drugs in the 6-Hz seizure model in mice.Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats.
P2860
Q24629140-E59BEC4D-6D8C-4621-B8E9-19DC02EE4952Q24644936-EE58958C-ED33-4C66-A926-AE4D04306BC0Q27014681-96BE6782-559E-45DB-8EBF-21BFFFFF28E3Q27014744-5A3180EF-C87F-4470-BFBB-06BE104AB8AFQ28537667-29504976-BA69-4E9F-9CAB-3FA2970807DEQ28833549-254A670D-2D94-40F4-B3D9-CC9E8DFBA065Q34596814-EB6FCD72-2816-4910-B0A9-149F73E555C0Q35837304-A5020D4A-86BB-4935-BBCD-E04AB6AB0BE4Q37156322-0EE6ABB0-AFC9-4C8A-877A-B884A5CC68F5Q37507327-042D0E85-440D-419B-A027-66E6D957F2E3Q37831297-2FC319A9-E3D5-45E9-A800-C21E0924711FQ37950518-BC6B74C2-14BC-4C01-9639-62146DA9A19FQ37964697-E0B550AF-B59B-42E0-9149-218A384AEB2BQ38244605-0FA24869-9B9B-405D-95BC-8BAF1FEF86FBQ42721754-6CFE8CB7-EE1E-4CB0-BBD1-69DC85C8D7FEQ45064896-D7FA1E60-94E5-49EE-BF53-3E151B53B2CDQ47585978-54379070-5351-4C28-B2DE-E3D27247D7E4
P2860
The novel antiepileptic drug lacosamide blocks behavioral and brain metabolic manifestations of seizure activity in the 6 Hz psychomotor seizure model.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The novel antiepileptic drug l ...... Hz psychomotor seizure model.
@en
The novel antiepileptic drug l ...... Hz psychomotor seizure model.
@nl
type
label
The novel antiepileptic drug l ...... Hz psychomotor seizure model.
@en
The novel antiepileptic drug l ...... Hz psychomotor seizure model.
@nl
prefLabel
The novel antiepileptic drug l ...... Hz psychomotor seizure model.
@en
The novel antiepileptic drug l ...... Hz psychomotor seizure model.
@nl
P1433
P1476
The novel antiepileptic drug l ...... Hz psychomotor seizure model.
@en
P2093
Gary E Duncan
Harold Kohn
P356
10.1016/J.EPLEPSYRES.2005.08.009
P577
2005-10-06T00:00:00Z